NYSE · DALIndustrialsTransportation & Logistics

Delta Air Lines financials

$84.87+1.00%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Q3 '25
Sep 30
Q2 '25
Jun 30
Q1 '25
Mar 31
Q4 '24
Dec 31
Q3 '24
Sep 30
Q2 '24
Jun 30
Q1 '24
Mar 31
Q4 '23
Dec 31
Q3 '23
Sep 30
Revenue$19.76B$15.85B$16.00B$16.67B$16.65B$14.04B$15.56B$15.68B$16.66B$13.75B$14.22B$15.49B
Gross profit$19.27B$15.43B$15.54B$16.19B$16.17B$13.61B$15.11B$15.21B$16.20B$9.71B$13.78B$15.04B
Gross margin97.5%97.3%97.1%97.1%97.1%96.9%97.1%97.0%97.2%70.7%96.9%97.1%
Operating income$1.86B$501.0M$1.47B$1.68B$2.10B$569.0M$1.72B$1.40B$2.27B$614.0M$1.32B$1.98B
Net income$1.60B-$289.0M$1.22B$1.42B$2.13B$240.0M$843.0M$1.27B$1.30B$37.0M$2.04B$1.11B
Net margin8.1%−1.8%7.6%8.5%12.8%1.7%5.4%8.1%7.8%0.3%14.3%7.2%
Diluted EPS$2.44$-0.44$1.85$2.17$3.27$0.37$1.29$1.97$2.01$0.06$3.15$1.72
EBITDA$1.86B$501.0M$5.51B$3.41B$2.10B$569.0M$5.56B$2.65B$3.73B$1.98B$1.32B$1.98B
Operating cash flow$1.59B$2.43B$2.26B$1.85B$1.86B$2.38B$1.89B$1.27B$2.45B$2.41B$545.0M$1.08B
Free cash flow$137.0M$1.23B$1.35B$688.0M$648.0M$1.15B$584.0M-$54.0M$1.14B$1.22B-$1.06B-$193.0M
Diluted shares658.0M652.0M658.0M654.0M652.0M652.0M652.0M647.0M648.0M645.0M647.0M644.0M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30Jun 30Mar 31
Cash & equivalents$4.67B$5.05B$4.31B$3.79B$3.33B$3.71B
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$15.05B$14.16B$15.21B$15.98B$16.16B$16.92B
Total assets$86.32B$84.43B$81.32B$79.62B$78.39B$77.34B
Total liabilities$64.51B$64.06B$60.46B$60.80B$60.95B$61.90B
Shareholders' equity$21.82B$20.38B$20.85B$18.82B$17.44B$15.45B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology